Acquisition Readiness
5
Minutes Read
Published
July 9, 2025
Updated
July 9, 2025

Structuring your company for future exits: Delaware flip, IP, tax and unified cap table

Learn how to choose the best company structure for selling a startup, including holding companies and IP strategies, to prepare for a smooth acquisition.
Glencoyne Editorial Team
The Glencoyne Editorial Team is composed of former finance operators who have managed multi-million-dollar budgets at high-growth startups, including companies backed by Y Combinator. With experience reporting directly to founders and boards in both the UK and the US, we have led finance functions through fundraising rounds, licensing agreements, and periods of rapid scaling.

The Best Company Structure for Selling a Startup in the US

For many UK-based startups, particularly in sectors like SaaS, Biotech, and Deeptech, the growth trajectory points west. The largest market, the deepest pools of venture capital, and the most likely strategic acquirers are often in the United States. This geographic reality creates an immediate structural challenge. Your UK Ltd is optimized for local operations, but US investors and buyers are looking for the familiarity and legal simplicity of a US entity. Getting this structure wrong early on can introduce significant friction, cost, and risk when you are preparing for acquisition due diligence, jeopardizing a potential exit. The best company structure for selling a startup is one that anticipates this future from the beginning.

The core tension for a UK-based company with US ambitions is that American venture capitalists and corporate acquirers are overwhelmingly predisposed to invest in or acquire a Delaware C-Corporation. It is the gold standard for US high-growth companies, with a predictable and well-understood body of corporate law that simplifies governance, stock issuance, and M&A transactions. A UK Ltd, while perfectly functional, can be a hurdle. It introduces perceived legal and tax complexities that can slow down a deal or even lead to valuation discounts.

The most common and effective solution is a corporate reorganization often called the “Delaware Flip.” This process rearranges your company into a holding company structure that satisfies the preferences of US investors while maintaining your UK operational base. The flip creates a clean, two-tier structure that is the optimal subsidiary setup for startups targeting a US exit.

The process generally involves three key steps:

  1. A new parent company (TopCo) is incorporated as a Delaware C-Corporation.
  2. The existing shareholders of your UK Ltd exchange all their shares for an equivalent number of shares in the new US TopCo.
  3. Your original UK Ltd becomes a wholly-owned subsidiary (SubCo) of the US parent, continuing to house your UK-based team and operations.

When structured correctly, this transaction can qualify for tax-free reorganization treatment under IRC Section 351 in the US and similar reliefs in the UK. The lesson that emerges across cases we see is that the timing of this flip is critical. Executing it at the pre-seed stage is a relatively straightforward legal process. Waiting until after a Series A, when your valuation is higher and you have more investors on the cap table, dramatically increases the cost, paperwork, and potential tax implications of the reorganization.

Managing Your Holding Company Structure: IP, Tax, and Operations

Once you have your US TopCo and UK SubCo in place, you must manage the relationship between them correctly to satisfy both US and UK authorities. This cross-border entity planning primarily revolves around intellectual property, cash flow, and operational services. Neglecting these areas can create significant tax implications of an exit and complications during due diligence.

Cross-Border IP Ownership Strategies

One of the most pressing questions is where your intellectual property should be housed. US acquirers generally prefer to see valuable IP held within the US parent entity they are acquiring. However, for R&D-heavy startups in Biotech or Deeptech, this creates a conflict with a valuable UK incentive. To claim UK R&D tax credits, HMRC requires the UK entity to own the IP it is developing. Forfeiting these credits can mean giving up a significant source of non-dilutive funding that is often critical in the early stages.

A practical approach is to initially house the IP in the UK SubCo to maximize these tax credits. To allow the US parent to commercialize the technology, the two entities enter into an Intercompany License Agreement. This legal document grants the US TopCo the exclusive rights to sell, market, and distribute the product in the US and other international markets in exchange for a royalty fee. This arrangement allows the UK entity to satisfy HMRC's ownership requirement while enabling the US parent to generate revenue, which is where investors expect to see it.

Cross-Border Entity Planning for Cash Flow and Services

Another key operational challenge is funding the UK team. How do you move money from the US parent, which receives the investment capital, to the UK subsidiary, which houses the R&D and operational staff, without creating a tax nightmare? This is typically handled through two mechanisms: a Management Services Agreement and Intercompany Loans.

The UK SubCo can charge the US TopCo a fee for the R&D, sales, and administrative work it performs under a Management Services Agreement. This formalizes the operational relationship. Any transactions, whether for services or licensing, must adhere to transfer pricing rules. This means intercompany agreements must be at 'arm's length' to satisfy both transfer pricing rules from the IRS and HMRC. For example, if your UK development team costs £500,000 annually in salaries and overhead, it cannot charge the US parent a nominal fee. The fee must reflect what two independent companies would agree upon, typically cost plus a reasonable margin (e.g., 5-15%). This prevents companies from artificially shifting profits to lower-tax jurisdictions and is a key area of scrutiny during due diligence. All these intercompany transactions must be properly documented and reconciled in your accounting systems, such as QuickBooks for the US entity and Xero for the UK one.

A Unified Cap Table: The Single Source of Truth for Your Equity

One of the most damaging and easily avoidable mistakes in a cross-border structure is maintaining separate, disconnected capitalization tables for the parent and subsidiary. This creates confusion, signals disorganization to potential acquirers, and can create legal ambiguity over ownership. Investors and buyers may apply valuation discounts due to the perceived risk and complexity. The solution is a single, unified cap table managed at the TopCo level.

All equity grants, regardless of an employee’s location, must be issued from the US Delaware C-Corporation parent. Modern cap table management platforms like Carta or Pulley are essential for this. They provide a single source of truth for your entire ownership structure, which is critical for preparing for acquisition due diligence. An acquirer’s diligence team should be able to see a clean, consolidated view. They expect to see the cap table for “Global SaaS Inc. (TopCo)” and find all shareholders listed together: a US-based founder, a UK-based founder, a US venture fund, and both US and UK employees with their respective stock options. All ownership must trace back cleanly to one entity.

This centralized approach also simplifies managing country-specific employee equity plans. You do not create a separate option pool for each entity. Instead, you create a single master equity incentive plan at the US TopCo level, and then implement country-specific sub-plans under that umbrella. For US employees, the company can grant standard options like ISOs or NSOs. For your UK team, you can still offer the highly advantageous EMI (Enterprise Management Incentive) scheme. The EMI plan is structured as a sub-plan, approved by HMRC, that draws from the main US TopCo’s option pool. This ensures everyone is an owner in the same parent company, aligning incentives across the entire organization and presenting a clean, professional structure to the outside world.

Key Exit Strategy Legal Considerations: A Founder's Checklist

Navigating a UK-US corporate structure is manageable for early-stage founders, provided you adhere to a few core principles from the outset. Your future exit strategy legal considerations depend on the groundwork you lay today.

First, make the foundational structural decision early. If a US exit is your most likely outcome, executing a Delaware Flip before you raise significant capital will save you substantial legal fees, tax headaches, and complexity down the road. The best company structure for selling a startup is proactive, not reactive.

Second, formalize the relationship between your entities. Do not leave intercompany dealings to informal agreements. Implement a simple Management Services Agreement and an Intercompany License Agreement from the start. These documents demonstrate operational rigor and ensure you comply with transfer pricing rules, a major focus for both tax authorities and acquirers.

Third, centralize your equity management. Use a dedicated platform like Carta or Pulley from day one to maintain a single, unified cap table at the US TopCo level. Ensure all employee option grants, whether US ISOs or UK EMIs, are issued from the parent company and are properly documented as such. This prevents critical errors that can delay or devalue an exit.

Finally, be deliberate with your IP ownership strategies. It is often advantageous to hold IP in the UK initially to benefit from R&D tax credits. However, you must have a clear legal framework, like a license agreement, that governs its use by the US parent, and a plan for how that IP will be handled in a sale. Taking these methodical steps ensures your corporate house is in order, allowing you to face due diligence with confidence and maximize the value of your exit. Continue at our Acquisition Readiness hub for templates and checklists.

Frequently Asked Questions

Q: When is the best time to do a Delaware Flip?

A: The ideal time is before you raise any significant priced equity round and while your valuation is low. Executing a flip pre-seed or alongside your first major funding round is far simpler and cheaper than doing it post-Series A, when a higher valuation and more complex cap table can create significant tax and legal hurdles.

Q: Can I just start with a US company from day one?

A: You can, but this may not be the best company structure for selling a startup if your core team and R&D are in the UK. This approach can make it difficult to qualify for UK-specific benefits like R&D tax credits or offer EMI options to your UK employees, which are powerful incentives for retaining talent.

Q: What are the biggest mistakes founders make with this holding company structure?

A: The most common errors are waiting too long to perform the flip, failing to create formal intercompany agreements for IP and services, and maintaining separate cap tables. These mistakes create complexity and risk that can deter investors, lower your valuation, and complicate preparing for acquisition due diligence.

Q: How does a Delaware Flip affect UK investors with SEIS/EIS tax relief?

A: This is a critical consideration. A standard share-for-share exchange in a flip can cause UK investors to lose their valuable SEIS/EIS relief. It is essential to work with legal and tax advisors who are experienced in structuring flips to preserve these benefits, often through specific transaction structures acceptable to HMRC.

This content shares general information to help you think through finance topics. It isn’t accounting or tax advice and it doesn’t take your circumstances into account. Please speak to a professional adviser before acting. While we aim to be accurate, Glencoyne isn’t responsible for decisions made based on this material.

Curious How We Support Startups Like Yours?

We bring deep, hands-on experience across a range of technology enabled industries. Contact us to discuss.